BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 356 filers reported holding BIONTECH SE in Q4 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,151,943 | +0.7% | 148,674 | 0.0% | 19.26% | +50.8% |
| Q2 2023 | $16,046,385 | -13.4% | 148,674 | 0.0% | 12.77% | -21.9% |
| Q1 2023 | $18,520,320 | -17.1% | 148,674 | 0.0% | 16.35% | -5.0% |
| Q4 2022 | $22,333,808 | +11.1% | 148,674 | 0.0% | 17.21% | +8.3% |
| Q3 2022 | $20,100,000 | -9.5% | 148,674 | 0.0% | 15.89% | -6.9% |
| Q2 2022 | $22,200,000 | -12.6% | 148,674 | 0.0% | 17.06% | +25.0% |
| Q1 2022 | $25,400,000 | -33.7% | 148,674 | 0.0% | 13.66% | +17.5% |
| Q4 2021 | $38,300,000 | -5.7% | 148,674 | 0.0% | 11.62% | -2.2% |
| Q3 2021 | $40,600,000 | -82.6% | 148,674 | -85.7% | 11.88% | -66.8% |
| Q2 2021 | $233,000,000 | +105.4% | 1,038,674 | 0.0% | 35.80% | +92.9% |
| Q1 2021 | $113,413,000 | +33.4% | 1,038,674 | 0.0% | 18.56% | -4.4% |
| Q4 2020 | $85,000,000 | – | 1,038,674 | – | 19.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |